Login

Forgot your password?
New User?
Remember me
banner banner

You are here:Home » Growth Factors, Cytokines » Growth Factors-Interleukin » Interleukin 22, Recombinant, Human (IL-22, CRF29, IL-TIF R1, IL-10 Related T Cell-derived Inducible Factor)

Interleukin 22, Recombinant, Human (IL-22, CRF29, IL-TIF R1, IL-10 Related T Cell-derived
Inducible Factor)

Pricing

  For pricing information, USA customers sign in.
  Outside USA? Please contact your distributor for pricing.

Specifications

Human IL-22 Interleukin-22 (IL-22), also known as IL-10-related T cell-derived inducible factor (IL-TIF) was initially identified as a gene induced by IL-9 in mouse T cells and mast cells. Human IL-22 cDNA encodes a 179aa residue protein with a putative 33aa signal peptide that is cleaved to generate a 147aa mature protein that shares ~79% and 22% aa sequence identity with mouse IL-22 and human IL-10, respectively. The human IL-22 gene is localized to chromosome 12q15. Although it exists as a single copy gene in human and in many mouse strains, the mouse IL-22 gene is duplicated in some mouse strains including C57B1/6, FVB and 129. The two mouse genes designated IL-TIFa and IL-TIFb, share > 98% sequence homology in their coding region. IL-22 has been shown to activate STAT-1 and STAT-3 in several hepatoma cell lines and upregulate the production of acute phase proteins. IL-22 is produced by normal T cells upon anti-CD3 stimulation in humans. Mouse IL-22 expression is also induced in various organs upon lipopolysaccharide injection, suggesting that IL-22 may be involved in inflammatory responses. The functional IL-22 receptor complex consists of two receptor subunits, IL-22R (previously an orphan receptor named CRF2-9) and IL-10Ra (previously known as CRF2-4), belonging to the class II cytokine receptor family.
Catalog #I8443-13B
Recombinant Human IL-22 is a single, non-glycosylated homodimeric polypeptide chain containing 2 x 146aa and having a total Mr 33,607D.
Sequence The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Pro-Ile-Ser.
Biological Activity rHuIL-22 is fully biologically active when compared to standard. The Biological Acitivity was determined by the ability to activiate STAT following receptor ligand interaction.
Storage and StabilityLyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile dH2O and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
SourceHuman, recombinant expressed in E. coli
PurityChromatographically purified ( 97% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain).
Dimers and Aggregates< 1% (silver-stained SDS-PAGE gel analysis).
Endotoxin< 0.1ng/ug
Concentration~0.1mg/ml
FormSupplied as a lyophilized powder in 40% mannitol, 30% HSA.
ReconstitutionReconstitute with sterile 18MO-cm H2O to a concentration > 100ug/ml.
Important NoteThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.


External Links